Condition 1: Osteoarthritis. Condition 2: Rheumatoid arthritis. Osteoarthritis of knee Rheumatoid arthritis with rheumatoid factor
Conditions
Interventions
Intervention 1: Control group: Patients receiving topical standard treatment including Razak Pharmaceutical Co. piroxicam 0.5% gel twice daily for one week. Intervention 2: Intervention group: Patient
Sponsors
Daroo Sazan Sorena Exir Company
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Experiencing pain in one or more joint Having acute (less than three weeks), Sub-acute (three weeks to three months) or chronic (more than three months) joint pain Age between 18 to 80 years old
Exclusion criteria
Exclusion criteria: Consumption of oral, rectal, or parenteral pain killers or anti-inflammation drugs including corticosteroids, NSAIDs, acetaminophen, narcotics, Herbal pain killers with scientifically-proven effect
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Joint pain in rest and during movement. Timepoint: The pain levels will be recorded daily from the first to the seventh day of initiating the clinical trial. Method of measurement: The pain level will be measured using numerical rating scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Amini
Shiraz University of Medical Sciences
Outcome results
None listed